The mouse constitutive androstane receptor (CAR) is a unique member of the nuclear receptor superfamily, for which an inverse agonist, the testosterone metabolite 5␣-androstan-3␣-ol (androstanol), and an agonist, the xenobiotic 1,4-bis[2-(3, 5-dichloropyridyloxy)] benzene, are known. In this study the role of the transactivation domain 2 (AF-2) of CAR was investigated, which is formed by the seven most carboxy-terminal amino acids of the receptor. The AF-2 domain was shown to be critical for the constitutive activity by mediating a ligand-independent interaction of CAR with coactivator (CoA) proteins. In addition this domain increased and decreased contact with CoAs in the presence of agonist and inverse agonist, respectively. In analogy to classical endocrine nuclear receptors, in CAR the charge clamp between K187 (in helix 3) and E355 (within the AF-2 domain) was expected to be critical for its interaction with CoAs. However, the hydrophobic amino acids L352, L353, and I356 on the surface of the AF-2 domain were found to be more important for this protein-protein interaction. Moreover, these amino acids and C357 were shown to be involved in the response of CAR to androstanol. Interestingly, the cysteine at position 357 appears to block classical endocrine responsiveness of CAR to agonists, since mutagenesis of this amino acid both reduced CoA interaction in the absence of ligand and drastically increased inducibility by 1,4-bis[2-(3, 5-dichloropyridyloxy)] benzene. We showed that this blockade is not due to an intramolecular disulfide bridge, but is probably caused by an interaction between C357 and Y336. (Molecular Endocrinology 17: 234-246, 2003)
The mouse constitutive androstane receptor (CAR) is a unique member of the nuclear receptor superfamily, for which an inverse agonist, the testosterone metabolite 5␣-androstan-3␣-ol (androstanol), and an agonist, the xenobiotic 1,4-bis[2-(3, 5-dichloropyridyloxy)] benzene, are known. In this study the role of the transactivation domain 2 (AF-2) of CAR was investigated, which is formed by the seven most carboxy-terminal amino acids of the receptor. The AF-2 domain was shown to be critical for the constitutive activity by mediating a ligand-independent interaction of CAR with coactivator (CoA) proteins. In addition this domain increased and decreased contact with CoAs in the presence of agonist and inverse agonist, respectively. In analogy to classical endocrine nuclear receptors, in CAR the charge clamp between K187 (in helix 3) and E355 (within the AF-2 domain) was expected to be critical for its interaction with CoAs. However, the hydrophobic amino acids L352, L353, and I356 on the surface of the AF-2 domain were found to be more important for this protein-protein interaction. Moreover, these amino acids and C357 were shown to be involved in the response of CAR to androstanol. Interestingly, the cysteine at position 357 appears to block classical endocrine responsiveness of CAR to agonists, since mutagenesis of this amino acid both reduced CoA interaction in the absence of ligand and drastically increased inducibility by 1,4-bis[2-(3, 5-dichloropyridyloxy)] benzene. We showed that this blockade is not due to an intramolecular disulfide bridge, but is probably caused by an interaction between C357 and Y336. C LASSICAL ENDOCRINE NUCLEAR receptors (NRs) regulate the transcription of genes in response to the rise and fall of the levels of natural endocrine hormones within tightly controlled physiological concentrations (1) . The adopted orphan NR constitutive androstane receptor (CAR) plays a key role in activating the transcription of genes encoding xenobiotic/steroid metabolizing enzymes, such as the cytochrome P450 monooxygenases (CYP) types 2B and 3A (2) . Induction of these enzymes confers a higher metabolic capacity to organisms, which contributes to their defense mechanisms against the xenochemical toxicity and carcinogenicity. CAR activity gets modulated in response to the xenobiotic phenobarbital (PB) and other PB-like ligands, such as the pesticide contaminant 1,4-bis[2-(3, 5-dichlorpyridyloxy)] benzene (TCPOBOP) in mice and the antimycotic drug clotrimazole in humans (3) . These compounds are structurally diverse, but show a similar ability to modulate the activity of CAR. Therefore, this NR has been proposed to function as xenosensor (4) .
NRs form a large family of transcription factors (48 genes in humans) (5) and are characterized by a highly conserved DNA-binding domain, which is formed by two zinc-finger motifs, and a ligand-binding domain (LBD) that is formed by 12 ␣-helical structures, of which the last one, helix 12, contains a short transactivation function 2 (AF-2) domain (6) . CAR belongs to a subgroup of the NR superfamily that also includes the receptors for 1␣,25-dihydroxyvitamin D 3 [1␣,25-dihydroxyvitamin D 3 , vitamin D receptor (VDR)], bile acids (farnesoid X receptor), and for oxysterols (liver X receptor). Its closest relative is, however, the receptor for pregnanes [pregnane X receptor (PXR)] (5). In contrast to classical endocrine NRs, such as VDR, that show a very selective ligand binding with dissociation constant (K d ) values in the order of 1 nM or less (7), adopted orphan NRs, such as CAR, display a relatively low affinity for their ligands (K d in the order of 1 M) (8) . CAR also differs from most other NRs by having a strong constitutive activity in the absence of ligand. This can be reduced by the binding of the inverse agonist, the testosterone metabolite 5␣-androstan-3␣-ol (androstanol) (9) .
Nuclear hormone-responsive genes are defined through the presence of specific recognition of binding sites, referred to as response elements (REs), in their promoter regions (10, 11) . CAR preferentially forms heterodimers with the retinoid X receptor (RXR) on REs that are formed by a direct repeat (DR) of hexameric binding sites (12) . Early reports indicated that CAR bound DR5-type REs (13, 14) , but subsequent reports have described the optimal complex formation of CAR-RXR heterodimers on DR4-type REs, such as in the PB response element module (PBREM) of the mouse CYP2B10 gene (15) and in the gene for the human-inducible NO synthase (iNOS) (16) . In general, transcriptional activation by NRs involves a liganddependent conformational change that promotes the recruitment of coactivator (CoA) proteins (17) . It was therefore hypothesized that the constitutive activity of CAR arises due to the ligand-independent recruitment of CoAs, which are released upon binding of the inverse agonist androstanol (3) .
The LBD of every ligand-activated NR serves as a molecular switch that interacts in its agonistic conformation with CoA proteins to activate target gene transcription (18) . The mouse-trap model (6) , which is based on the crystal structures of several classical NRs, suggests that binding of ligand induces a conformational change of the LBD. The major consequences of this ligand-induced conformational change is a repositioning of the AF-2 domain (19) that, together with amino acids of helices 3 and 5, provides an interface for the binding of CoAs (20) . The CoAs then contact components of the basal transcriptional machinery, which results in an enhanced transcription of NR target genes. The crystal structure of the LBDs of the PXR (21) and peroxisome proliferator-activated receptor (PPAR) (22, 23) indicated that the conformational change of the AF-2 domain of adopted orphan NRs is not as drastic as for the classical NRs.
In this study the role of the seven most carboxyterminal amino acids of mouse CAR, which form the AF-2 domain, was investigated to characterize the nature of CAR's constitutive activity. The hydrophobic amino acids L352, L353, and I356 were more critical for the ligand-independent activity and agonistinduced increased interaction of CAR with CoA proteins than the charge clamp amino acids K187 and E355. The mutagenesis of C357 reduced CoA interaction of CAR in the absence of ligand and drastically increased inducibility by TCPOBOP. This suggests that the cysteine in the AF-2 domain blocks the classical endocrine responsiveness in this orphan NR.
RESULTS
To determine the impact of the AF-2 domain on the transactivation properties of the adopted orphan receptor mouse CAR in comparison to that of the classical endocrine receptor human VDR, luciferase reporter gene assays were performed in the transiently transfected model cell line MCF-7 (Fig. 1) . The amount of overexpression of wild-type and carboxy-terminaltruncated CAR and VDR proteins in MCF-7 cells was found to be comparable (data not shown). Ligandtriggered CAR and VDR signaling was determined on a classical 1␣,25(OH) 2 D 3 RE (the DR3-type RE of the rat atrial natriuretic factor gene, Fig. 1A) , a multi-functional RE (the DR4-type RE of the human iNOS gene, Fig. 1B) , and a classical CAR RE (the PBREM of the mouse CYP2B10 gene, Fig. 1C ). The ligand-independent (basal) activity of endogenous receptor was taken as a reference for each RE (lane 1). Stimulation with 1␣,25(OH) 2 D 3 demonstrated the expression of endogenous VDR in MCF-7 cells (27-and 9-fold induction of reporter gene activity on the DR3-type RE and the PBREM, respectively, lane 3), whereas no response to the treatment with the CAR agonist TCPOBOP indicates that there is insufficient amounts of endogenous CAR in these cells (lane 2). On all three REs, CAR overexpression increased the basal activity 11-to 17-fold (lane 4), and treatment with TCPOBOP resulted in a further 2.0-to 2.7-fold induction of this elevated level (lane 5). Truncation of the 10 most carboxy-terminal amino acids of CAR (which deletes the AF-2 domain) resulted in the complete loss both of constitutive activity (lane 6) and agonist inducibility (lane 7). On the DR4-type RE, the basal activity was significantly lower than that without any CAR overexpression (Fig. 1B , compare lanes 1 and 6). Overexpression of VDR had no effect on the basal activity of the DR3-type RE and the PBREM (Fig. 1 , A and C, compare lanes 1 and 8) and even decreased the basal activity of the DR4-type RE (Fig. 1B) . Stimulation with 1␣,25(OH) 2 D 3 resulted in the DR3-type RE in a 535-fold induction of reporter gene activity (Fig. 1A, lane 9) , whereas on the two other REs stimulation factors of only approximately 5-fold were determined (Fig. 1, B and C) . Removal of the AF-2 domain of VDR decreased the basal activity on the DR3-type RE (Fig. 1A, lane 10) but not on the two other REs (Fig. 1, B and C) . This truncated receptor drastically reduced or even abolished the inducibility by 1␣,25(OH) 2 D 3 (lane 11) via a dominantnegative effect on endogenous VDR. In summary, the AF-2 domain of CAR appeared to be essential both for the receptor's constitutive activity and its inducibility by agonists. This observation is independent from the structure of the RE that was used to monitor CAR signaling.
Using combined gel shift/supershift assays, we next investigated the role of the AF-2 domain of mouse CAR in interaction with CoA proteins (Fig. 2) . VDR served again as a reference in these experiments. Both wild-type and AF-2 deleted versions of in vitro translated CAR and VDR formed heterodimers with RXR on a DR4-type RE (lanes 1, 5, 9, and 11). The addition of 0.1 g of bacterially produced transcriptional intermediary factor 2 (TIF2) CoA protein resulted For a detailed analysis of the AF-2 domain of CAR alanine scanning mutagenesis was performed for the seven carboxy-terminal amino acids of the receptor. In reference to wild-type and AF-2-deleted CAR the functional activity of these seven point-mutants was tested in MCF-7 cells using the DR4-type RE of the human iNOS gene (Fig. 3A ) and the PBREM of the mouse CYP2B10 gene (Fig. 3B ) as reporters. The panel of ligand inducibility on the DR4-type RE (Fig.  3A , top) indicated that only L352A and the AF-2 deletion lost their responsiveness to TCPOBOP. Remarkably, C357A became nearly 30-fold inducible by TCPOBOP (compared with 2.2-fold for wild-type CAR). The inverse agonistic effect of androstanol was completely lost with L352A, L353A, I356A, C357A, and the AF-2 deletion. Interestingly, with L352A, L353A, I356A, and the AF-2 deletion androstanol became slightly agonistic. On wild-type CAR, application of both ligands simultaneously neutralized their effects. In the case of the mutants L353A, G354A, I356A, and C357A this combined ligand treatment resulted in additive agonistic effect. The effects of the point mutants were more drastic in relation to the relative basal activity (Fig. 3A, bottom panel) . The point mutants L352A, L353A, E355A, I356A, and C357A and the AF-2 deletion reduced the basal activity by 90% or more, S358A by 75%, and G354A by only 10%. On the classical CAR RE, the PBREM (Fig. 3B) , similar results were observed with only minor, RE-specific deviations. These include the reduced TCPOBOP inducibility of C357A (only 10.5-fold) and reduced loss of basal activity of E355A (only 80%) and S358A (only 60%) compared with wild-type CAR. A minor difference was found also concerning a responsiveness of L352A to TCPOBOP, which was found to be statistically significant on the PBREM but not to the DR4-type RE. In summary, the mutagenesis of L352, L353, I356, and C357 resulted in drastically reduced basal activities of CAR in living cells. In contrast, C357A shows strong agonist responsiveness. The impact of E355 is lower than expected, and the importance of S358 and G354 is minor.
The detailed CoA interaction profile of the AF-2 domain was addressed using the single-point mutations in supershift assays (Fig. 4) . In this series of experiments the inverse CAR agonist androstanol was applied alone and in combination with the agonist TCPOBOP. It is important to note that limiting amounts of bacterially expressed TIF2 were used to observe ligand-specific effects on receptor-CoA interaction. For this reason the relative migration difference between the CAR-RXR-DNA and CAR-RXR-TIF2-DNA complexes was reduced. As expected, in the absence of ligand wild-type CAR interacts strongly with TIF2, which conforms to the results shown in Fig. 2 . The limiting amounts of TIF2 allowed the detection of an enhanced interaction between CAR and CoA protein after addition of agonist and a reduced interaction in the presence of inverse agonist. The combination of both ligands resulted in a neutral effect, i.e. interaction levels with TIF2 were comparable to that without ligand. The ligand-dependent interaction profile of the mutant G354A with TIF2 was found to be very similar to that of wild-type CAR. E355A and S358A also resemble the profile of wild-type CAR, but their overall weaker interaction with TIF2 is shown by the reduced migratory distances between the supershifted complex (CAR-RXR-TIF2-DNA) and the gel shift complex (CAR-RXR-DNA). The most interesting mutation is Reporter gene assays were performed with extracts from MCF-7 cells that were transiently transfected with luciferase reporter constructs containing four copies of the DR3-type RE from rat atrial natriuretic factor gene (A), four copies of the DR4-type RE from the human iNOS gene (B), or one copy of the PBREM of the mouse CYP2B10 gene (C). Wild-type and carboxy-terminal truncated mouse CAR and human VDR expression vectors were also cotransfected as indicated. Cells were treated for 16 h with either solvent, 1 M TCPOBOP, or 100 nM 1␣,25(OH) 2 D 3 as indicated, and relative luciferase activities were measured. Data were normalized to the activity of the RE without receptor overexpression. Columns represent the mean from three experiments and bars indicate SDs. Heterodimers of in vitro translated wild-type and carboxy-terminal truncated mouse CAR and human VDR with RXR were formed in the presence and absence of respective agonists. Combined gel shift/supershift experiments were performed using a 32 P-labeled DR4-type RE and indicated amounts of bacterially expressed GST-TIF2 fusion protein. Protein-DNA complexes were resolved from free probe through 8% nondenaturing polyacrylamide gels. Representative gels are shown. Relative protein-DNA complex formation was quantified using an FLA-3000 reader (Fuji Photo Film Co., Ltd.). Columns represent the mean of three experiments and bars indicate SD.
C357A, which showed in the absence of ligand or in the presence of inverse agonist only weak interaction with TIF2, but strong interaction in the presence of agonist. Finally, L352A, L353A, I356A, and the AF-2 deletion showed no interaction with TIF2 irrespective of ligand presence. This indicates that the supershift assay may not be sensitive enough to detect the ligand modulation of the low basal activity of the mutants L352A, L353A, and I356A. Moreover, a direct comparison of the ability of all CAR mutants for complex formation with RXR on the DR4-type RE did not show any significant difference to that of CAR wt (data not shown). Taken together, the in vitro CoA interaction profile of the individual amino acids of CAR's AF-2 domain correlates well with their activity in living cells, even though the supershift assay is less sensitive than the reporter gene assay.
Mutagenesis of the charge clamp amino acids K187 and E355 reduced the basal activity by 80% compared with wild-type CAR when the PBREM was used as a reporter for CAR signaling in MCF-7 cells (Fig. 5A) . This reduction was not as drastic as observed with the mutants L352A, L353A, I356A, and C357A and the AF-2 deletion (Fig. 3) . Moreover, the inducibility of the charge clamp mutants by TCPOBOP was reduced, and the inverse agonistic effect of androstanol was completely lost. This was confirmed by supershift assays (Fig. 5B) . Using standard nonsaturating TIF2 amounts (0.1 g), both K187A and E355A displayed a clear interaction with TIF2 in the absence of ligand. This interaction could be moderately enhanced by the addition of TCPOBOP and abolished by androstanol treatment. The combination of agonist with inverse agonist resulted in a complex with approximately the same strength of interaction as observed for mutated receptor in the absence of ligand.
Two hypotheses could explain the drastically increased ligand-dependent responsiveness of C357A. C357 may be able to form a disulfide bridge with other cysteines in the LBD, which would lock wild-type CAR into its agonistic conformation. Alternatively, the sulfhydryl group of C357 could interact with Y336, which is homologous to the F422-H397 interaction in VDR (24) (see Fig. 7 ). To investigate the first hypothesis, the two other cysteines within the LBD of CAR at positions 229 and 233 were mutated separately into alanines. Reporter gene assays were performed with extracts from MCF-7 cells that were transiently transfected with luciferase reporter constructs containing four copies of the DR4-type RE from the human iNOS gene (A) or one copy of the PBREM of the mouse CYP2B10 gene (B). Expression vectors for wild-type and point-mutated mouse CAR were also cotransfected as indicated. Cells were treated for 16 h with solvent, 1 M TCPOBOP, 10 M androstanol, or a combination of both ligands and relative luciferase activities were measured. Data were normalized to the basal activity of the respective CAR mutant (top panels). In addition, the basal activity of each CAR mutant was normalized to that of wild-type CAR (bottom panels). Columns represent the mean from three experiments and bars indicate SD. Two-tail, paired Student's t tests were performed, and P values were calculated in reference to the respective solvent controls (top panels) or wild-type basal activity (bottom panels) (*, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001).
Fig. 4. Effects of CAR AF-2 Domain Mutants on CoA Recruitment
Heterodimers of in vitro translated wild-type and point-mutated mouse CAR protein with RXR protein were formed in the presence of solvent, the agonist TCPOBOP, the inverse agonist androstanol, or a combination of both. Combined gel shift/ supershift experiments were performed using a 32 P-labeled DR4-type RE and limiting amounts of bacterially expressed GST-TIF2 fusion protein (0.03 g). Protein-DNA complexes were resolved from free probe through 8% nondenaturing polyacrylamide gels. Representative gels are shown, but please note that they are not derived from the same experimental series.
For the second hypothesis C357 was mutated into serine and tyrosine, Y336 was mutated into alanine, cysteine, and phenylalanine, and the point-mutants Y336A/C357A, Y336C/C357Y, and L352A/C357A were created. Using the PBREM reporter gene construct in MCF-7 cells as a probe for CAR signaling (Fig.  6 ), the first hypothesis could not be proven, since the ligand response profile of both C229A and C233A was found to be very similar to that of wild-type CAR (Fig.  6A) . This excludes the possibility that C357 is involved in an intramolecular disulfide bridge. The mutant C357S showed the same functional profile as C357A, suggesting that both the hydroxyl group of a serine and the short hydrophobic side chain of an alanine at position 357 drastically decrease CoA interaction and increase agonist inducibility. In contrast, an aromatic tyrosine at position 357 reduces the inducibility of CAR by TCPOBOP, but retains the responsiveness to androstanol and decreases the basal activity only by 40%. This indicates that the sulfhydryl group of C357 is critical for keeping the basal activity of CAR high and its responsiveness to ligand low. Increasing the volume of the residue and modifying the polarity, such as a mutation to tyrosine, seems to balance the loss of basal activity but compromises with reduced ligand responsiveness. Interestingly, in comparison to wildtype CAR, Y336A showed an increased TCPOBOP inducibility and a nearly abolished response to androstanol. The reduction in basal activity and increase in agonist response of Y336A was not as drastic as with C357A, but showed the same tendency. In contrast, Y336C behaved similar to wild-type CAR, but showed lower ligand responsiveness and slightly reduced basal activity. The mutant Y336F lost inducibility by TCPOBOP, kept some responsiveness to androstanol, and did not affect the basal activity. This indicates that both the polar hydroxyl group as well as the large volume of Y336 are important for the full ligand responsiveness of CAR, but not very critical for the basal activity of the receptor. All three double-point mutants, Y336A/C357A, Y336C/C357Y, and L352A/C357A, showed nearly abolished response to ligand, which was expected because of the profile of the individual mutants Y336C, C357Y, and L352. Interestingly, C357A/Y336A and L352A/C357A reduced the basal activity of CAR by 80-90%, whereas Y336C/C357Y did not influence it significantly. The latter result suggests that the permutation of the residues keeps their interaction stable and in this way the basal activity high, but destroys specific (direct or indirect) contacts with the ligands. Taken together, the functional profiles of all three double-point mutants suggest that C357, Y336, and the CoA interacting amino acid L352 are functionally linked, such as F422, H397, and L417 in VDR (24) (25) (26) . Finally, a dose response to TCPOBOP was performed with wild-type CAR in comparison to A, Reporter gene assays were performed with extracts from MCF-7 cells that were transiently transfected with a luciferase reporter construct containing one copy of the PBREM of the mouse CYP2B10 gene and expression vectors for wild-type and point-mutated mouse CAR (as indicated). Cells were treated for 16 h with solvent, 1 M TCPOBOP, 10 M androstanol, or a combination of both ligands, and relative luciferase activities were measured. Data were normalized to the respective basal activity of wild-type CAR. Columns represent the mean from three experiments and bars indicate SDs. Two-tailed, paired Student's t tests were performed and P values were calculated in reference to the respective solvent controls (*, P Ͻ 0.05; **, P Ͻ 0.01). B, Heterodimers of in vitro translated CAR K187A and CAR E355A protein with RXR protein were formed in the presence of solvent, TCPOBOP, androstanol, or a combination of both. Combined gel shift/supershift experiments were performed using a 32 P-labeled DR4-type RE and standard amounts of bacterially expressed GST-TIF2 fusion protein (0.1 g). Protein-DNA complexes were resolved from free probe through 8% nondenaturing polyacrylamide gels. Representative gels are shown. Reporter gene assays were performed with extracts from MCF-7 cells that were transiently transfected with a luciferase reporter construct containing one copy of the PBREM of the mouse CYP2B10 gene and expression vectors for wild-type and point-mutated mouse CAR (as indicated). Cells were treated for 16 h with solvent, 1 M TCPOBOP, 10 M androstanol, or a combination of both ligands (A), solvent (B), and graded concentrations of TCPOBOP (C), and relative luciferase activities were measured. Data were normalized to the basal activity of the respective CAR mutant (A) or to that of wild type CAR (B and C). Columns (A and B) and data points (C) represent the mean from three experiments, and bars indicate SDs. Two-tailed, paired Student's t tests were performed, and P values were calculated in reference to the respective solvent controls (top panels) or wild-type basal activity (bottom panels) (*, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001).
C357A using the PBREM reporter gene system in MCF-7 cells (Fig. 6C) . The half-maximal activation (EC 50 ) value of wild-type CAR (110 nM) was found to be only less than two times lower than that of C357A (200 nM). This demonstrates that a mutagenesis of C357 into alanine has only minor effects on the affinity of CAR for TCPOBOP but does not clarify whether or not this amino acid is involved in a direct contact with the agonist.
DISCUSSION
The critical role of the AF-2 domain in agonist-triggered transactivation is well established for classical endocrine NRs (19, 27) but is less understood for adopted orphan receptors. This study demonstrated that in contrast to VDR, CAR interacts with CoA proteins even in the absence of ligand and that the AF-2 domain is essential for this interaction. This indicates that the constitutive activity of CAR in living cells is based on the ligand-independent interactions of CAR with CoA proteins via its AF-2 domain. As expected on the basis of previous reports (14, 24) , for both types of NRs the AF-2 domain is essential for their liganddependent interaction with CoAs.
The analysis of the functional profile of the individual amino acids (L352-S358) of the AF-2 domain of CAR revealed striking differences to comparable studies of the AF-2 domains of classical endocrine receptors, such as VDR (24) or retinoid acid receptor (28) . The most surprising observation of this study is the strong agonist responsiveness of the mutant C357A, which represents a rare case of a gain of function mutant. Similar to classical endocrine receptors, the negatively charged amino acid E355 [homologous to E420 in VDR (25); see Fig. 7 ] and its positively charged counterpart K187 [K246 in VDR (29) ] would be expected to play an important role in fixing the CoA-CAR interaction. In fact, the mutagenesis of both amino acids reduced the basal activity of CAR in living cells as well as its interaction with TIF2 but was less effective than mutating L352, L353, and I356. Interestingly, these three amino acids as well as E355 are exposed to the outer surface of the receptor (Fig. 7) . The hydrophobic character of L352, L353, and I356 suggests that they would favor interacting with other hydrophobic amino acids, such as the lysines of the LXXLL NR interaction motif of CoA proteins (30) .
In the case of VDR the optimal distance between the charge clamp amino acids E420 and K246 for forming an effective contact with CoAs was found to be 19 Å and is achieved by fixing the position of helix 12 by an interaction between F422 and H397 (24, 26) (see Fig.  7 ). In addition, H397 is correctly positioned by a contact with the hydroxyl group at carbon 25 of the agonist 1␣,25(OH) 2 D 3 . In the absence of ligand, helix 12 is not fixed and does not allow efficient CoA contact. In contrast, the AF-2 domain of CAR, even in the absence of ligand, appears to be in a favorable position for CoA contact. In common with other adopted orphan receptors, such as the PXR (21) and PPAR (22, 23) , binding of agonist does not result in major conformational changes within the LBD of CAR and only optimizes the position of the AF-2 domain. The amino acid C357 is exposed toward the hydrophobic core of mouse CAR and therefore unlikely to be involved in any direct CoA contact, but it seems to block full agonist responsiveness of the receptor. C357 appears to be very specific in its interaction with Y336 and is not involved in the formation of disulfide bridges. A modeling of the structure of helices 11 and 12 on the basis of the VDR structure (Fig. 7) predicts that C357 interacts with Y336. In fact, mutagenesis of Y336 alone and in combination with C357 suggests that both amino acids are functionally linked, such as F422 and H397 in VDR. The specificity of the interaction between these two amino acids is supported by the observation that the double mutant Y336C/C357Y showed no effect on the basal activity of CAR, i.e. that these two residues stabilize helix 12 independent of their orientation. In contrast to VDR, in CAR the stabilization of helix 12 by the C357-Y336 interaction occurs even in the absence of ligand. A mutation of C357 or Y336 allows a free movement of helix 12 in the absence of ligand and provides CAR with a functional profile comparable to classical endocrine NRs, i.e. low basal activity and high ligand inducibility. PPAR agonists have been shown to contact the AF-2 domain amino acids Y465 and Y437 of PPAR␣ or PPAR␦, respectively (31) , whereas the VDR agonist 1␣,25-(OH) 2 D 3 is known to interact with H397 in VDR (26) . The mutation C357A increases ligand inducibility from a very low basal activity, but it lowers the ligand affinity by a factor of nearly 2. The C357-Y336 interaction seems to be reinforced and optimized by the agonist TCPOBOP, whereas the Y336C/C357Y double mutant of CAR has lost its responsiveness to ligand. This suggests that one of the two amino acids is involved, at least indirectly, in ligand binding. The principal role of C357 seems to be the stabilization of helix 12 via an interaction with Y336, but it is possible that Y336 directly contacts the ligand in the way that H397 does in VDR.
A very recently published structural model of mouse CAR (32) covered its entire LBD and was based on the crystal structure of human PXR (21) , which showed similar level of homology to mouse CAR than does human VDR. The most interesting suggestion of this model is that the negatively charged carboxy group at the carboxy terminus of helix 12 and the positively charged amino acid K205 of helix 4 should form a charge clamp. This charge clamp should then keep helix 12 in position for a contact with CoA proteins. We agree with Dussault et al. (32) concerning the impact of K205, since the mutant K205A has a similar functional profile as C357A (data not shown). However, we are not sure whether the carboxy terminus is the preferential interaction partner of K205, because an extension of helix 12 by three amino acids did not influence the basal activity of CAR (data not shown). Taken together, the comparison of both models suggests that there seems to be more than one pair of amino acids that contribute to the constitutive activity of CAR.
In conclusion, this study demonstrates that the function of the AF-2 domain of CAR differs from that of classical endocrine NRs. Within the adopted orphan receptor, movement of helix 12 seems to be reduced via an interaction between C357 and Y336, which is only optimized by contact with a ligand. The direct contact of the AF-2 domain with CoAs is mediated by the hydrophobic amino acids L352, L353, and I356 on the solvent-facing surface of helix 12, and the contribution of the charged amino acids E355 and K187 to the CoA interaction is only of minor importance.
MATERIALS AND METHODS

Compounds
Androstanol was obtained from Steraloids (Newport, RI), TCPOBOP was synthesized and purified according to Honkakoski et al. (33) , and 1␣,25(OH) 2 D 3 was kindly provided by L. Binderup (Leo Pharmaceuticals Products, Ballerup, Denmark). 1␣,25(OH) 2 D 3 was dissolved in 2-propanol, whereas the other compounds were dissolved in dimethyl sulfoxide; further dilutions were made in dimethyl sulfoxide (for in vitro experiments) or in ethanol (for cell culture experiments).
DNA Constructs
Protein Expression Vectors. The full-length cDNA for mouse CAR (14) was subcloned into the T 7 /CMV promoterdriven pCMX expression vector. Full-length cDNAs for human VDR (34) and human RXR␣ (35) were subcloned into the T 7 /SV40 promoter-driven pSG5 expression vector (Stratagene, La Jolla, CA). The same constructs were used for both T 7 RNA polymerase-driven in vitro transcription/translation of the respective cDNAs and for viral promoter-driven overexpression of the respective proteins in mammalian cells. Truncated versions of mouse CAR (CAR ⌬349Ϫ58 ) and VDR (VDR ⌬413Ϫ27 ), which were lacking the AF-2 domain, were generated by introducing via QuikChange site-directed mutagenesis protocol (Stratagene) a stop codon at positions 349 and 413, respectively. Other point mutants of mouse CAR were performed by the same mutagenesis protocol. All mutants were confirmed by sequencing. Glutathione S-transferase (GST) Fusion Protein Construct. The NR interaction domain of human TIF2 (spanning amino acids 646-926) (36) was subcloned into the GST fusion vector pGEX (Amersham Pharmacia Biotech, Uppsala, Sweden). Reporter Gene Constructs. Four copies of the DR3-type RE from rat atrial natriuretic factor gene promoter (core sequence 5Ј-AGAGGTCATGAAGGACA-3Ј) (37) , four copies of the DR4-type RE from the human iNOS promoter (core sequence 5Ј-GTGGTTCATGCCGGTTCA-3Ј) (16) , and one copy of the PBREM of the mouse CYP2B10 gene promoter (containing two DR4-type REs) (38) were fused with the thymidine kinase (tk) minimal promoter driving the firefly luciferase (LUC) reporter gene. The hexameric binding NR binding motifs are indicated in bold.
In Vitro Translation and Bacterial Overexpression of Proteins
In vitro translated wild-type or mutated mouse CAR, human VDR, and RXR proteins were generated by coupled in vitro transcription/translation using rabbit reticulocyte lysate as recommended by the supplier (Promega Corp., Madison, WI). Protein batches were quantified by test translations in the presence of [ 35 S]methionine. The specific concentration of the receptor proteins was adjusted to approximately 4 ng/l after taking the individual number of methionine residues per protein into account. Bacterial overexpression of GST-TIF2 646Ϫ926 was obtained from the Escherichia coli BL21(DE3)pLysS strain (Stratagene) containing the respec-tive expression plasmids. Overexpression was stimulated with 0.25 mM isopropyl-␤-D-thio-galactopyranoside for 3 h at 37 C, and the proteins were purified and immobilized by glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech) according to the manufacturer's protocol. Proteins were eluted in the presence of glutathione.
Gel Shift and Supershift Assays
Gel shift assays were performed with equal amounts (ϳ10 ng) of the appropriate in vitro translated protein. The proteins were incubated for 15 min in a total volume of 20 l binding buffer (10 mM HEPES, pH 7.9; 150 mM KCl; 1 mM dithiothreitol; 0.2 g/l poly(deoxyinosine-deoxycytidine); and 5% glycerol). For supershift experiments 0.1-3 g of bacterially expressed GST-TIF2 646Ϫ926 proteins were added to the reaction mixture. Approximately 1 ng of 32 P-labeled doublestranded oligonucleotides (50,000 cpm) corresponding to one copy of the DR4-type RE from the rat pit-1 promoter (core sequence 5Ј-GAAGTTCATGAGAGTTCA-3Ј) (39) was then added, and incubation was continued for 20 min at room temperature. The hexameric binding NR binding motifs are indicated in bold. Protein-DNA complexes were resolved by electrophoresis through 8% nondenaturing polyacrylamide gels in 0.5ϫ TBE [45 mM Tris, 45 mM boric acid, 1 mM EDTA (pH 8.
3)] and quantified on a FLA3000 reader (Fuji Photo Film Co., Ltd., Tokyo, Japan) using Image Gauge software (Fuji Photo Film Co., Ltd.).
Transfection and Luciferase Reporter Gene Assays
MCF-7 human breast cancer cells were seeded into six-well plates (10 5 cells/ml) and grown overnight in phenol red-free DMEM supplemented with 5% charcoal-stripped fetal bovine serum. Plasmid DNA-containing liposomes were formed by incubating 1 g of a reporter plasmid, 1 g of RXR expression vector, and 1 g of an expression vector for wild-type or mutated mouse CAR or human VDR with 10 g N- [1-(2, 3-dioleoyloxy) propyl]-N,N,N-trimethylammonium methylsulfate (Roth, Karlsruhe, Germany) for 15 min at room temperature in a total volume of 100 l. After dilution with 900 l phenol red-free DMEM, the liposomes were added to the cells. Phenol red-free DMEM supplemented with 500 l 15% charcoal-stripped fetal bovine serum was added 4 h after transfection. At this time, NR ligands were also added. The cells were lysed 16 h after onset of stimulation using the reporter gene lysis buffer (Roche Molecular Biochemicals, Mannheim, Germany), and the constant light signal luciferase reporter gene assay was performed as recommended by the supplier (Canberra-Packard, Groningen, The Netherlands). The luciferase activities were normalized with respect to protein concentration, and induction factors were calculated as the ratio of luciferase activity of ligand-stimulated cells to that of solvent controls.
Molecular Modeling
The crystal structure of the LBD of human VDR (PDB entry 1DB1) (26) was used as template for modeling, since it has high homology to the mouse CAR LBD. The amino acid sequences of VDR and CAR were aligned and the amino acid residues V418, L419, V421, F422, G423, and H397 of VDR were mutated in silico to the respective amino acid residues of mouse CAR (L353, G354, I356, C357, S358, and Y336, respectively) by using the mutation command of Swiss PDB Viewer (v.3.7b2). The torsion angles of the side chain of Y336 were adjusted manually. Energy minimization was done by GROMOS96 implementation of Swiss-PBD Viewer using the 43B1 parameter set. Computations were performed in vacuo without reaction field with 2000 steps of the Steepest Descent method and terminated when the energy difference between two steps was below 0.05 kJ/mol.
